A class of novel 1,2-benzisothiazol-3(2H)-one derivatives containing isopropanolamine structure, their preparation methods and applications

By introducing an isopropanolamine structure into the parent compound of 1,2-benzisothiazol-3(2H)-one, a novel 1,2-benzisothiazol-3(2H)-one derivative was synthesized, which solved the problems of high toxicity and insufficient targeted inhibition ability in the existing technology, and achieved a highly efficient bactericidal effect against rice bacterial blight and citrus canker.

CN123106571APending Publication Date: 2026-11-17GUIZHOU UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202611112381.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2026-07-24
Publication Date
2026-11-17

AI Technical Summary

Technical Problem

Existing 1,2-benzisothiazol-3(2H)-one compounds exhibit high non-target toxicity to humans, livestock, and aquatic organisms in agricultural applications, making it difficult to combine highly efficient bactericidal activity with low toxicity, and they cannot target and inhibit the formation of pathogenic bacterial biofilms.

Method used

By introducing isopropanolamine structures into the parent compound of 1,2-benzisothiazol-3(2H)-one, a series of novel 1,2-benzisothiazol-3(2H)-one derivatives were synthesized through nucleophilic substitution with epoxide and ring-opening reaction with epoxide, thereby enhancing their hydrophilicity and antibacterial efficacy.

Benefits of technology

The synthetic compound exhibited excellent inhibitory activity against rice bacterial blight and citrus canker, with EC50 values ​​significantly lower than those of commercial fungicides, effectively inhibiting pathogen biofilm formation and reducing environmental toxicity risks.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN123106571A_ABST
    Figure CN123106571A_ABST
Patent Text Reader

Abstract

This invention discloses a novel class of 1,2-benzisothiazole-3(2) containing an isopropanolamine structure. H )-Ketone derivatives, the structural formula of which is shown in (1), where R is an aniline derivative, a benzylthiophenol derivative, a piperidine derivative, 2-thiophene methylamine, 2-furan methylamine, or a piperazine derivative. Biological tests showed that the synthesized compound was effective against pathogens at a concentration of 100 μg / mL. Xo and Xac All showed good inhibitory activity, with some compounds even approaching or achieving complete inhibition. The target compounds exhibited good inhibitory activity against... Xo EC 50 The values ​​ranged from 3.36 μg / mL to 39.71 μg / mL, and the EC50 values ​​for Xac were... 50 The concentrations ranged from 4.87 μg / mL to 40.92 μg / mL, all significantly superior to the commercial fungicides pymetrozine and thiamethoxam. Further mechanistic studies revealed that the concentrations were achieved by inhibiting... Xo Biofilm formation provides antibacterial protection and effectively interferes with the infection process of pathogens on rice plants. (1)
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention relates to the fields of chemistry and pesticide science, specifically to a novel class of 1,2-benzisothiazole-3(2) containing an isopropanolamine structure. H )-Ketone derivatives, their preparation methods and applications. Background Technology

[0002] With the continued growth of the global population, global food production needs to increase to meet human food needs, making food security a core global issue. Plant pathogens and pests are key factors restricting food production capacity, with plant pathogens causing huge reductions in food yields and severe economic losses every year. Rice, as the world's staple food, provides over 23% of global calories. Half of Asia's population relies on rice as their staple food, and rice bacterial blight (… Xoo It is the most destructive bacterial pathogen that harms rice, and can cause a 20% to 30% reduction in rice yield after infection. Xoo It can invade the vascular tissue of rice through wounds and stomata, relying on biofilms to enhance its own resistance, secreting cellulase and amylase to degrade the rice cell wall, and interfering with the plant's immunity through the type III secretion system. Infected rice leaves develop water-soaked streaks at the tips and margins, gradually turning yellow and dying. Seedlings wilt and die within 2-3 weeks after infection, and photosynthesis in mature plants decreases significantly, severely affecting rice yield and quality. In addition, similar pathogens such as citrus canker and kiwifruit canker can also cause devastating damage to economic crops.

[0003] Chemical pesticides are currently the mainstream method for controlling bacterial diseases. Commercially available traditional fungicides such as thiamethoxam (BT) and thiamethoxam (TC) rely solely on direct bactericidal action due to their single toxicity, lacking the ability to regulate the virulence factors of pathogens. Long-term, repeated application of these agents can rapidly induce drug resistance in pathogens, leading to a gradual decline in their efficacy. Furthermore, traditional pesticides pose a high risk of residue, and excessive application can easily cause water and soil pollution, which is inconsistent with the requirements of green agriculture. Even with continuous research and development of new agents, traditional fungicides cannot fundamentally solve the problem of pathogen resistance evolution. Therefore, there is an urgent need to develop novel green agricultural fungicides with novel mechanisms of action, low toxicity, environmental friendliness, and resistance-resistant properties.

[0004] Biofilms are extracellular matrix communities formed by bacterial aggregation, composed of extracellular polysaccharides, proteins, and nucleic acids, and can stably attach to biological / abiotic interfaces. Biofilms can isolate pesticides and evade host immune killing. The drug resistance of bacteria inside biofilms is nearly a thousand times that of planktonic bacteria, making them a core key target for the continuous infection and drug resistance of pathogens. Targeted inhibition of biofilm formation is an important research and development direction for novel pesticides.

[0005] 1,2-Benzisothiazol-3(2) is currently available. H)-ketones are broad-spectrum isothiazolinone fungicides with both antibacterial and antiviral activities. They are widely used in industrial and agricultural preservation and crop disease control, and can control various bacterial and fungal diseases in rice, wheat, fruits, and vegetables. However, this parent compound has significant safety drawbacks: long-term skin contact with humans can easily induce allergic dermatitis, and it has high toxicity to aquatic non-target organisms such as fish, resulting in insufficient ecological safety and limiting its large-scale application in the field.

[0006] The existing technology lacks 1,2-benzisothiazole-3 (2 H Derivatives modified with isopropanolamine active fragments, based on ketones, cannot reduce non-target toxicity to humans, animals, and aquatic organisms while retaining the excellent bactericidal activity of the parent compound. They also lack low-toxicity lead compounds that target and inhibit pathogenic bacterial biofilms, making them unsuitable for the low-residue, low-inducibility, and high-safety requirements of green agriculture. Summary of the Invention

[0007] The technical problem to be solved by this invention is: using 1,2-benzisothiazole-3(2 H Using the )-ketone structure as a lead compound, the isopropanolamine structure, which exhibits hydrophilicity, structural flexibility, and excellent antibacterial efficacy, is introduced to expand 1,2-benzisothiazole-3(2) H The application of ketones in agriculture is hoped to lead to the discovery of novel, green, and highly efficient antibacterial agents with high activity and a clear mechanism of action.

[0008] The technical solution of the present invention is a novel 1,2-benzisothiazole-3(2) containing an isopropanolamine structure. H )-ketone derivatives, the structural formula of which is shown in (1): (1) Where R is an aniline derivative, a thiophenol derivative, a piperidine derivative, 2-thiophene methylamine, 2-furan methylamine, or a piperazine derivative.

[0009] This invention relates to a novel 1,2-benzisothiazole-3(2) containing an isopropanolamine structure. H )-Ketone derivatives, including the following compounds: Novel 1,2-benzisothiazole-3(2) containing isopropanolamine structure H The preparation method of )-ketone derivatives is shown in the following reaction formula: Novel 1,2-benzisothiazole-3(2) containing isopropanolamine structure H Applications of ketone derivatives, including their use in bactericides.

[0010] Preferably, the fungicide is a fungicide that kills rice bacterial blight and citrus canker.

[0011] The beneficial effects achieved by this invention compared with the prior art are as follows: This invention utilizes 1,2-benzisothiazole-3 (2... H Using 1,2-benzisothiazole-3(2-)-ketone as the parent compound and utilizing the unique active nitrogen site on its heterocycle, a series of novel 1,2-benzisothiazole-3(2-)-ketones containing isopropanolamine structures were successfully synthesized via nucleophilic substitution with epoxide bromide and ring-opening reaction. H )-Ketone derivative bactericide. Biological tests showed that the synthesized compound was effective against pathogens at a concentration of 100 μg / mL. Xoo and Xac All showed good inhibitory activity, with some compounds even approaching or achieving complete inhibition. Further screening results showed that these compounds were effective against... Xoo EC 50 The concentration ranged from 3.36 μg / mL to 39.71 μg / mL, which was significantly better than that of the commercial fungicide bismuth subtilis (BT, EC). 50 = 44.0 μg / mL) and thiamethoxam (TC, EC) 50 = 84.26 μg / mL). EC50 for Xac 50 The concentration ranged from 4.87 μg / mL to 40.92 μg / mL, which was significantly better than that of the commercial fungicide bismuth subtilis (BT, EC). 50 = 52.59 μg / mL) and thiamethoxam (TC, EC) 50 = 72.53 μg / mL), further mechanistic studies showed that it was through inhibition Xoo The biofilm forms antibacterial film, effectively interfering with the infection process of pathogens on rice plants. Attached Figure Description

[0012] Figure 1 A 12 Control effect on rice bacterial blight (concentration: 200 μg / mL); Figure 2 Inhibitory effect on biofilm formation; Figure 3 A 12 right Xoo The impact on pathogenicity; Detailed Implementation

[0013] Example 1 Synthesis of intermediates and target compounds With 1,2-benzisothiazole-3(2 H Starting with a ketone, intermediate 1 is generated via a nucleophilic substitution reaction. Intermediate 1 then reacts with different substituted compounds to yield compound A1-A. 39 .

[0014] Preparation of intermediate 1: 2-(ethylene oxide-2-ylmethyl)benzo[ d Isothiazine-3(2) H Preparation of )-ketone In a clean, dry 100 mL round-bottom flask, 33.80 mmol of 1,2-benzisothiazol-3(2H)-one and 43.94 mmol of potassium carbonate were added. 20 mL of N,N-dimethylformamide (DMF) was then added dropwise as the reaction solvent, and the mixture was stirred at room temperature for 20 minutes. After the system stabilized, 50.70 mmol of epichlorohydrin was slowly added dropwise. The reaction was allowed to proceed for 24 h at room temperature after the addition was complete. After the reaction was complete, the reaction mixture was extracted with ethyl acetate (EA) and a saturated ammonium chloride solution. The organic extracts were combined and dehydrated with anhydrous sodium sulfate. The organic solvent was removed by vacuum distillation. The crude product was purified by silica gel column chromatography (200-300 mesh) using ethyl acetate:petroleum ether as eluent (4:1) to obtain intermediate 1.

[0015] Target compound A1-A 39 Synthesis (taking the synthesis of compound A1 as an example). Compound A1 To a dry 100 mL round-bottom flask, intermediate 1 (1.08 mmol) and potassium carbonate (1.88 mmol) were added sequentially, followed by the addition of 20 mL isopropanol (IPA) as the reaction solvent using a dropper. The mixture was magnetically stirred at room temperature for 20 minutes until homogeneous, at which point 2-fluorobenzylamine (1.52 mmol) was added. After the reaction was complete, the reaction mixture was extracted multiple times with dichloromethane. All organic extracts were combined and dried using anhydrous sodium sulfate. Organic reagents were removed by rotary evaporation under reduced pressure. The crude product was then purified by silica gel column chromatography (200-300 mesh, eluent: methanol:dichloromethane = 100:1) to obtain the target product A1 (compound A1-A). 39 (General method) Target compound A1 White soil, yield 42.81%, mp 127.1-127.9 ℃; 1 HNMR (500MHz, CDCl3)δ 7.91 (d, J = 7.9 Hz, 1H, CO-C= CH), 7.77 (d, J = 8.3 Hz, 1H, S-C= CH ), 7.58 –7.46 (m, 1H, S-C=CH- CH ), 7.40 – 7.31 (m, 2H, F-Ar-4,6H ), 7.24 (s, 1H, CO-C=CH- CH ), 7.15 – 6.97 (m, 2H, F-Ar-3,5H), 4.66 – 4.51 (m, 2H, NH- CH2 ), 4.27 –4.14 (m, 1H, HO- CH ), 3.95 – 3.84 (m, 2H, N- CH2 ), 2.89 (dd, J = 12.0, 4.1 Hz,1H, NH- CH2 -Ar), 2.80 (dd, J = 12.0, 7.9 Hz, 1H, NH- CH2 -Ar). 13 C NMR (126 MHz,CDCl3)δ 171.32, 162.97, 151.69, 131.78, 128.85, 125.11, 124.52, 123.28,120.20, 71.07, 68.09, 67.55, 60.52, 57.54, 56.86, 53.11, 21.17, 14.29. 19 F NMR(471 MHz, CDCl3) δ -62.31. HRMS (ESI) [M+H]+ calcd for C 17 H 18 O2N2FS: 333.1068,found: 333.1055. Target compound A2 White solid, yield 86.67%, m. p. 77.2-77.7 °C; 1 H NMR (500 MHz, CDCl3)δ 7.86 (d, J = 8.0 Hz, 1H, CO-C= CH ), 7.72 (d, J = 8.3 Hz, 1H, S-C= CH), 7.51 –7.44 (m, 1H, S-C=CH- CH ), 7.33 (t, J = 7.5 Hz, 1H, CO-C=CH- CH ), 7.24 (td, J = 8.0,5.9 Hz, 1H,CH3-C= CH ), 7.10 – 7.00 (m, 2H, CH2-C= CH ,CH3-C-CH= CH ), 6.92 (td, J =8.4, 2.7 Hz, 1H, CH3-C-CH= CH ), 4.63 – 4.49 (m, 2H,N- CH2 ), 4.20 (ddt, J = 8.1,5.9, 4.0 Hz, 1H,HO- CH ), 3.87 – 3.73 (m, 2H,NH-CH2-Ar), 2.90 – 2.69 (m, 2H,NH- CH2 ). 13 C NMR (126 MHz, CDCl3) δ 164.01, 162.96, 162.06, 151.68, 142.54,130.06, 128.91, 125.10, 124.59, 123.77, 123.18, 120.26, 115.11, 114.17,71.42, 68.56, 53.30, 51.25. 19 F NMR (471 MHz, CDCl3) δ -112.92. HRMS (ESI) [M+H] + calcd for C 17 H 18 O2N2FS: 333.1068, found: 333.1054. Target compound A3 White solid, yield 64.43%, m. p. 106.8-107.1 °C; 1 H NMR(400 MHz,CDCl3) δ 7.87 (d, J = 7.8 Hz, 1H, CO-C=CH), 7.75 (d, J= 8.2 Hz, 1H, S-C=CH), 7.51(t, J = 7.6 Hz, 1H, S-C=CH- CH ), 7.36 (t, J = 7.5 Hz, 1H, CO-C=CH- CH ), 7.29 – 7.22(m, 4H,F-Ar-2,3,5,6H), 4.57 (qd, J = 11.2, 5.0 Hz, 2H,N- CH2 ), 4.17 (tt, J = 7.9,4.0 Hz, 1H,HO- CH ), 3.83 – 3.74 (m, 2H, NH- CH2 -Ar), 2.86 (dd, J = 12.2, 4.0 Hz,1H, NH- CH2 ), 2.77 (dd, J = 12.2, 7.8 Hz, 1H, NH- CH2 ). 13 C NMR (101 MHz, CDCl3) δ163.19, 162.86, 160.76, 151.61, 135.45, 129.73, 128.84, 124.98, 124.50,123.06, 120.17, 115.36, 71.28, 68.52, 53.01, 51.02. 19 F NMR (471 MHz, CDCl3) δ-115.18. HRMS (ESI) [M+H] + calcd for C 17 H 18 O2N2FS: 333.1068, found: 333.1051. Target compound A4 White solid, yield 57.51%, m. p. 117.2-118.5 °C; 1 H NMR (600 MHz,CDCl3) δ 7.90 (d, J = 8.0 Hz, 1H, CO-C=CH), 7.75 (d, J = 8.2 Hz, 1H, S-C=CH),7.51 (ddd,J = 8.2, 7.0, 1.1 Hz, 1H, S-C=CH- CH ), 7.38 – 7.34 (m, 3H, CO-C=CH- CH , Cl-Ar-3,6H), 7.21 (pd, J = 7.4, 1.8 Hz, 2H, Cl-Ar-4,5H), 4.61 (dd, J = 11.2,4.0 Hz, 1H,HO- CH ), 4.54 (dd, J = 11.2, 6.0 Hz, 1H, NH- CH2 -Ar), 4.20 (ddt, J =8.0, 6.1, 4.0 Hz, 1H, NH- CH2 -Ar), 3.97 – 3.90 (m, 2H, N-CH2), 2.90 – 2.86 (m,1H, NH- CH2 ), 2.79 (dd, J = 12.2, 8.1 Hz, 1H, NH- CH2 ), 13 C NMR (126 MHz, CDCl3) δ163.00, 151.74, 137.18, 133.92, 130.31, 129.72, 128.89, 128.67, 126.98,125.14, 124.56, 123.24, 120.27, 71.36, 68.46, 51.29, 50.94. HRMS (ESI) [M+H] + calcd for C 17 H 18 O2N2ClS: 349.0772, found: 349.0760. Target compound A5 White solid, yield 53.86%, m. p. 92.2-92.8 °C; 1 H NMR (400 MHz, CDCl3)δ 7.89 (dt, J = 8.1, 1.0 Hz, 1H, CO-C= CH ), 7.78 – 7.73 (m, 1H, S-C= CH), 7.51(ddd, J = 8.2, 7.0, 1.2 Hz, 1H, S-C= CH ), 7.39 – 7.32 (m, 2H, S-C=CH- CH , Cl-C- CH ), 7.25 – 7.17 (m, 3H, Cl-Ar-3,5,6H), 4.64 – 4.53 (m, 2H, NH- CH2 -Ar), 4.19(ddt, J = 7.9, 6.0, 4.0 Hz, 1H,HO- CH ), 3.85 – 3.76 (m, 2H,N- CH2 ), 2.87 (dd, J =12.2, 4.0 Hz, 1H, NH- CH2 ), 2.79 (dd, J = 12.2, 7.8 Hz, 1H, NH- CH2 ). 13 C NMR (101MHz, CDCl3) δ 162.76, 151.50, 141.88, 134.17, 129.61, 128.71, 128.07, 127.15,126.09, 124.87, 124.39, 122.97, 120.06, 71.20, 68.47, 53.10, 50.98.. HRMS(ESI) [M+H] + calcd for C 17 H 18 O2N2ClS: 349.0772, found: 349.0760. Target compound A6 White solid, yield 64.36%, m. p. 125.3-126.1 °C; 1 H NMR (400 MHz,CDCl3) δ 7.90 (d, J = 8.1 Hz, 1H, CO-C= CH ), 7.77 (d, J = 8.3 Hz, 1H, S-C= CH ),7.53 (t, J = 7.6 Hz, 1H, S-C=CH ), 7.38 (t, J = 7.5 Hz, 1H, S-C=CH- CH ), 7.29 (dd, J = 8.7, 5.5 Hz, 2H, Cl-Ar-3,5H), 7.00 (t, J = 8.7 Hz, 2H,Cl-Ar-2,6H), 4.62 (dd,J = 11.2, 3.9 Hz, 1H, HO- CH ), 4.55 (dd, J = 11.2, 6.1 Hz, 1H, NH- CH2 -Ar), 4.18(ddt, J = 7.8, 6.0, 3.9 Hz, 1H, NH- CH2 -Ar), 3.86 – 3.76 (m, 2H,N-CH2), 2.89 (dd, J = 12.2, 4.0 Hz, 1H, NH- CH2 ), 2.79 (dd, J = 12.2, 7.8 Hz, 1H,NH- CH2 ). 13 C NMR(101 MHz, CDCl3) δ 163.31, 152.07, 138.77, 133.24, 129.89, 129.27, 129.02,125.43, 124.95, 123.51, 120.62, 71.74, 69.02, 53.49, 51.48. HRMS (ESI) [M+H] + calcd for C 17 H 18 O2N2ClS: 349.0772, found: 349.0759. Target compound A7 White solid, yield 28.46%, m. p. 109.3-110.4 °C; 1 H NMR (500 MHz,CDCl3) δ 7.92 (d, J = 8.1 Hz, 1H, CO-C= CH ), 7.77 (d, J = 8.2 Hz, 1H, S-C=CH ), 7.57 – 7.49 (m, 2H, S-C=CH- CH , Br-Ar-5H ), 7.40 – 7.35 (m, 2H, S-C=CH-CH- CH , Br-Ar-6H), 7.28 (dd, J = 8.5, 7.2 Hz, 1H, Br-Ar-3H), 7.13 (td, J = 7.6, 1.8 Hz, 1H, Br-Ar-4H), 4.66 – 4.53 (m, 2H, NH- CH ), 4.20 (ddt, J = 7.9, 6.0, 4.0 Hz, 1H, HO- CH ), 3.96 – 3.87 (m, 2H, NH- CH2 -Ar), 2.89 (dd, J = 12.2, 4.0 Hz, 1H, NH- CH2 ), 2.80 (dd, J = 12.2, 7.9 Hz, 1H, NH- CH2 ). 13 C NMR (126 MHz, CDCl3) δ 163.01, 151.73, 138.82, 133.02, 130.43, 128.95, 128.90, 127.61, 125.14, 124.57, 124.16, 123.25, 120.28, 71.35, 68.48, 53.68, 50.88. HRMS (ESI) [M+H] + calcd for C 17 H 18 O2N2BrS: 393.0267, found: 393.0258. Target compound A8 White solid, yield 67.2%, m. p. 97.1-98.6 °C; 1 H NMR (400 MHz, CDCl3) δ 7.90 (dt, J = 8.1, 1.0 Hz, 1H, CO-C= CH ), 7.77 (dt, J= 8.2, 0.9 Hz, 1H, S-C= CH ), 7.56 – 7.47 (m, 2H, S-C=CH- CH ,Br-Ar-2H ), 7.42 – 7.36 (m, 2H, S-C=CH-CH- CH , Br-Ar-4H ), 7.24 (s, 1H, Br-Ar-6H), 7.19 (t, J = 7.7 Hz, 1H, Br-Ar-5H),4.66 – 4.52 (m, 2H, NH- CH2 -Ar), 4.18 (ddt, J = 7.9, 6.1, 4.0 Hz, 1H, HO- CH ),3.86 – 3.77 (m, 2H, N- CH2 ), 2.88 (dd, J = 12.2, 4.0 Hz, 1H, NH- CH2 ), 2.80 (dd, J =12.1, 7.7 Hz, 1H, NH- CH2 ). 13 C NMR (101 MHz, CDCl3) δ 163.03, 151.79, 142.46,131.24, 130.35, 130.19, 128.98, 126.81, 125.13, 124.66, 123.24, 122.72,120.33, 71.46, 68.78, 53.33, 51.19. HRMS (ESI) [M+H] + calcd for C 17 H 18 O2N2BrS:393.0267, found: 393.0259. Target compound A9 White solid, yield 73.99%, m. p. 101.7-102.4 °C; 1 H NMR (500 MHz,CDCl3) δ 7.91 – 7.86 (m, 1H, CO-C= CH ), 7.77 (d, J = 8.2 Hz, 1H, S-C= CH ), 7.53(ddd,J = 8.2, 7.0, 1.2 Hz, 1H, S-C=CH- CH ), 7.46 – 7.42 (m, 2H, Br-Ar-3,5H),7.38 (ddd, J = 8.0, 7.0, 0.9 Hz, 1H, S-C=CH-CH- CH ), 7.20 (d, J = 8.6 Hz, 2H, Br-Ar-2,6H), 4.62 (dd, J = 11.3, 3.9 Hz, 1H, N- CH2 ), 4.55 (dd, J = 11.3, 6.1 Hz, 1H,N- CH2 ), 4.17 (ddd, J = 7.7, 6.1, 3.9 Hz, 1H, HO- CH ), 3.83 – 3.75 (m, 2H, NH- CH2 -Ar), 2.87 (dd, J = 12.1, 4.0 Hz, 1H, NH- CH2 ), 2.78 (dd, J = 12.1, 7.7 Hz, 1H, NH- CH2 ). 13 C NMR (101 MHz, CDCl3) δ 163.03, 151.81, 138.96, 131.70, 129.98,128.99, 125.14, 124.67, 123.23, 121.08, 120.35, 71.43, 68.74, 53.23, 51.13.HRMS (ESI) [M+H] + calcd for C 17 H 18 O2N2BrS: 393.0267, found: 393.0252. Target Compound A 10 White solid, yield 51.94%, m. p. 74.7-75.2 °C; 1 H NMR (400 MHz, CDCl3)δ 7.90 (dt, J= 8.1, 1.0 Hz, 1H, CO-C= CH ), 7.77 (d, J = 8.1 Hz, 1H, S-C= CH ), 7.63(t, J = 8.3 Hz, 2H, S-C=CH- CH , F3C-Ar-5H), 7.52 (ddd, J = 8.2, 7.0, 1.2 Hz, 2H,S-C= CH , F3C-Ar-3H), 7.40 – 7.33 (m, 2H, F3C-Ar-5,6H), 4.64 (dd, J = 11.2, 3.9Hz, 1H, HO- CH ), 4.57 (dd, J = 11.2, 6.1 Hz, 1H, NH- CH2 -Ar), 4.20 (ddt, J = 7.8,6.0, 4.0 Hz, 1H, NH- CH2 -Ar), 4.01 (s, 2H, N- CH2 ), 2.93 (dd, J = 12.2, 4.0 Hz,1H, NH- CH2 ), 2.84 (dd, J = 12.1, 7.8 Hz, 1H, NH- CH2 ). 13 C NMR (126 MHz, CDCl3) δ163.00, 151.73, 138.52, 132.07, 130.40, 128.92, 128.50, 127.22, 126.10,125.69, 125.11, 124.59, 123.21, 120.28, 71.38, 68.62, 51.34, 49.90. 19 F NMR(471 MHz, CDCl3) δ -59.28. HRMS (ESI) [M+H] + calcd for C 18 H 18 O2N2F3S: 383.1036,found: 383.1023. Target Compound A 11 White solid, yield 45.71%, m. p. 137.8-138.2 °C; 1 ¹H NMR (500 MHz, CDCl₃) δ 7.89 (d, J = 8.0 Hz, 1H, CO-C= CH ), 7.75 (d, J = 8.6 Hz, 1H, S-C= CH ),7.62 (t, J = 8.0 Hz, 2H, F₃C-Ar-4,5H), 7.55 – 7.48 (m, 2H, S-C=CH- CH , CF₃-Ar-5H), 7.38 – 7.32 (m, 2H, S-C= CH 1, F₃C-Ar-6H), 5.28 (s, 1H, HO- CH ), 4.66 –4.51 (m, 2H, 11, N- CH2 ), 4.20 (ddt, J = 8.0, 6.3, 3.7 Hz, 1H, N- CH2 ), 4.00 (s,2H, NH- CH2 -Ar), 2.92 (dd, J = 12.0, 4.0 Hz, 1H, NH- CH2 ), 2.83 (dd, J = 12.0, 8.0Hz, 1H, NH- CH2 ). 13 ¹³C NMR (126 MHz, CDCl₃) δ 162.99, 151.71, 138.45, 132.09,130.40, 129.76, 128.92, 127.22, 126.09, 125.11, 124.59, 123.20, 120.27,71.38, 68.57, 53.59, 51.39, 49.88. 19 ¹⁹F NMR (471 MHz, CDCl₃) δ -59.26. HRMS(ESI) [M+H] + calcd for C 18 H 18 O₂N₂F₃S: 383.1036, found: 383.1022. Target compound A12 White soild, yield 60.88%, m. p. 84.3-84.9 ℃; 1 H NMR (500 MHz, CDCl3)δ 7.89 – 7.84 (m, 1H,CO-C= CH ), 7.75 (d, J = 7.9 Hz, 1H, S-C= CH ), 7.56 (d, J = 8.3Hz, 2H, F3C-Ar-3,5H), 7.53 – 7.49 (m, 1H, S-C=CH- CH ), 7.43 (d, J = 8.3 Hz, 2H,F3C-Ar-2,6H), 7.35 (t, J = 7.6 Hz, 1H, S-C= CH ), 4.58 (qd, J = 11.4, 5.0 Hz, 2H,N- CH2 ), 4.21 (ddt, J = 7.9, 6.2, 4.1 Hz, 1H, HO- CH ), 3.92 – 3.83 (m, 2H, NH- CH2 -Ar), 2.87 (dd, J = 12.2, 4.0 Hz, 1H, NH- CH2 ), 2.79 (dd, J = 12.0, 7.9 Hz, 1H, NH- CH2 ). 13 C NMR (126 MHz, CDCl3) δ 162.96, 151.70, 144.00, 129.55, 129.29,128.98, 128.42, 125.50, 125.05, 124.63, 123.14, 120.31, 71.40, 68.70, 53.32,51.23. 19 F NMR (471 MHz, CDCl3) δ -62.31. HRMS (ESI) [M+H] + calcd forC 18 H 18F3N2O2S: 383.1036, found: 383.1017. Target compound A 13 White solid, yield 39.02%, m. p. 74.8-76.2 °C; 1 1H NMR (500 MHz, CDCl3)δ 7.94 (d, J = 8.0 Hz, 1H, CO-C= CH ), 7.89 (d, J = 8.0 Hz, 1H, O2N-Ar-3H ), 7.75(d, J = 8.2 Hz, 1H, O2N-Ar-5H), 7.60 – 7.54 (m, 2H, S-C= CH , O2N-Ar-4H), 7.51 (t, J = 7.6 Hz, 1H, S-C=CH- CH ), 7.42 – 7.34 (m, 2H, S-C=CH-CH- CH , O2N-Ar-6H), 4.61(dd, J = 11.2, 3.9 Hz, 1H, NH- CH2 -Ar), 4.55 (dd, J = 11.2, 6.1 Hz, 1H, HO- CH ),4.22 – 4.16 (m, 1H, NH- CH2 -Ar), 4.13 – 4.04 (m, 2H, N- CH ), 2.89 (dd, J = 12.2,4.0 Hz, 1H, NH- CH2 ), 2.81 (dd, J = 12.2, 7.7 Hz, 1H, NH- CH2 ). 13C NMR (126 MHz,CDCl3) δ 162.99, 151.70, 149.15, 135.20, 133.36, 131.35, 128.93, 128.29,125.08, 124.98, 124.61, 123.21, 120.27, 71.39, 68.76, 51.39, 50.87. HRMS(ESI) [M+H] + calcd for C 17 H 18 O4N3S: 360.1013, found:360.0998. Target compound A 14 White solid, yield 38.64%, m. p. 116.6-116.9 °C; 1 H NMR (500 MHz,CDCl3) δ 8.22 (s, 1H, O2N-Ar-4H), 8.13 – 8.09 (m, 1H, O2N-Ar-2H), 7.89 (d, J =8.0 Hz, 1H, CO-C= CH ), 7.77 (d, J = 8.3 Hz, 1H, O2N-Ar-5H), 7.69 (d, J = 7.7 Hz,1H, S-C= CH ), 7.57 – 7.46 (m, 2H, O2N-Ar-6H, S-C=CH- CH ), 7.41 – 7.35 (m, 1H,S-C=CH-CH- CH ), 4.64 (dd, J = 11.3, 3.9 Hz, 1H, HO- CH) , 4.58 (dd, J = 11.3, 6.2Hz, 1H, NH- CH2 -Ar), 4.22 (ddd, J = 7.4, 6.0, 3.8 Hz, 1H, NH- CH2 -Ar), 3.95 (d, J= 2.9 Hz, 2H, N- CH2 ), 2.91 (dd, J = 12.1, 4.1 Hz, 1H, NH-CH2 ), 2.83 (dd, J = 12.1,7.5 Hz, 1H, NH- CH2 ). 13 C NMR (126 MHz, CDCl3) δ 162.98, 151.75, 148.43, 142.28,134.32, 129.48, 129.02, 125.02, 124.67, 123.15, 123.01, 122.34, 120.35,71.47, 68.98, 53.09, 51.28. HRMS (ESI) [M+H] + calcd for C 17 H 18 O4N3S: 360.1013,found:360.0998. Target compound A 15 White solid, yield 69.88%, m. p.84.5-85.4 °C; 1 H NMR (500 MHz, CDCl3) δ7.91 (d, J = 8.3 Hz, 1H, CO-C=CH), 7.76 (d, J = 8.3 Hz, 1H, S-C= CH ), 7.55 – 7.49(m, 1H, S-C=CH- CH ), 7.37 (t, J = 7.6 Hz, 1H, S-C=CH-CH- CH ), 7.32 – 7.27 (m,1H, H3C-Ar-6H), 7.17 (d, J = 2.8 Hz, 3H, H3C-Ar-3,4,5H), 4.66 – 4.51 (m, 2H, N- CH2 ), 4.25 – 4.16 (m, 1H, HO- CH ), 3.84 (q, J = 13.3 Hz, 2H, NH- CH2 -Ar), 2.98 –2.81 (m, 2H, NH- CH2 -Ar), 2.36 (s, 3H,CH3). 13C NMR (126 MHz, CDCl3) δ 163.00, 151.71, 137.47, 136.52, 130.52, 128.92, 127.44, 126.12, 125.13, 124.59, 123.25, 120.28, 71.34, 68.36, 51.50, 41.00, 29.81, 19.16. HRMS (ESI) [M+H] + calcd for C 18 H 21 O2N2S: 329.1318, found: 329.1303. Target compound A 16 White solid, yield 44.38%, m. p. 77.5-78.6 °C; 1 H NMR (400 MHz, CDCl3) δ 7.88 (d, J = 7.9 Hz, 1H, CO-C= CH ), 7.74 (d, J = 8.2 Hz, 1H, S-C= CH ), 7.53 – 7.46 (m, 1H, S-C=CH- CH ), 7.35 (t, J = 7.6 Hz, 1H, S-C=CH-CH- CH ), 7.20 (t, J = 7.5 Hz, 1H, H3C-Ar-6H), 7.14 – 7.03 (m, 3H, H3C-Ar-2,4,5H), 4.58 – 4.48 (m, 2H, 11, HO- CH ), 4.26 – 4.18 (m, 1H, NH- CH2 ), 3.84 – 3.74 (m, 2H, NH- CH2 -Ar), 2.87 (dd, J =12.1, 3.8 Hz, 1H, NH- CH2 ), 2.79 (dd, J = 12.2, 8.4 Hz, 1H, NH- CH2 ), 2.32 (s, 3H, CH3). 13C NMR (101 MHz, CDCl3) δ 162.89, 151.59, 138.95, 138.23, 129.13, 128.84, 128.48, 128.11, 125.38, 124.52, 123.16, 120.17, 71.24, 68.20, 53.64, 51.13, 50.44, 21.41. HRMS (ESI) [M+H] + calcd for C 18 H 21 O2N2S: 329.1318, found: 329.1306. Target compound A 17 White solid, yield 78.46%, m. p. 119.8-120.2 °C; 1 H NMR (400 MHz, CDCl3) δ 7.90 (d, J = 8.1 Hz, 1H, CO-C= CH ), 7.76 (d, J = 8.3 Hz, 1H, S-C= CH ), 7.51(t, J = 7.6 Hz, 1H, S-C=CH- CH ), 7.37 (t, J = 7.5 Hz, 1H, S-C=CH-CH- CH ), 7.21 (d, J = 7.9 Hz, 2H, H3C-Ar-2,6H), 7.13 (d, J = 7.9 Hz, 2H, H3C-Ar-3,5H), 4.62 – 4.50(m, 2H, N- CH2 ), 4.18 (tt, J = 8.1, 4.0 Hz, 1H, HO- CH ), 3.85 – 3.72 (m, 2H, NH- CH2 -Ar), 2.88 (dd, J = 12.1, 3.9 Hz, 1H, NH- CH2 ), 2.79 (dd, J = 12.2, 8.0 Hz, 1H,NH- CH2), 2.33 (s, 3H, CH3). 13 C NMR (151 MHz, CDCl3) δ 163.37, 152.09, 137.24, 129.63, 129.24, 128.55, 125.50, 124.91, 123.60, 120.62, 71.74, 68.82, 53.91, 51.35, 30.16, 21.57. HRMS (ESI) [M-H] + calcd for C 18 H 21 O2N2S: 329.1318, found: 329.1303. Target compound A 18 White solid, yield 51.75%, m. p. 76.5-76.9 °C; 1 H NMR (400 MHz, CDCl3) δ 7.87 (d, J = 8.1 Hz, 1H, CO-C= CH ), 7.73 (d, J = 8.2 Hz, 1H, S-C= CH ), 7.52 – 7.45 (m, 1H, S-C=CH- CH ), 7.33 (t, J = 7.6 Hz, 1H, S-C=CH-CH- CH ), 7.21 (t, J = 8.1 Hz, 1H, H3CO-Ar-6H), 6.91 – 6.87 (m, 2H, H3CO-Ar-4,5H), 6.78 (dd, J = 7.8, 3.1 Hz, 1H, H3CO-Ar-3H), 4.57 – 4.49 (m, 2H, NH- CH2 -Ar ), 4.25 – 4.18 (m, 1H, HO- CH ), 3.81 – 3.78 (m, 2H, NH- CH2 ), 3.27 (s, 3H, OCH3), 2.87 (dd, J = 12.1, 3.9 Hz, 1H, NH- CH2 ), 2.79 (dd, J= 12.2, 8.2 Hz, 1H, NH- CH2 ). 13 C NMR (101 MHz, CDCl3) δ162.84, 159.72, 151.55, 140.90, 129.51, 128.76, 125.01, 124.46, 123.11,120.52, 120.12, 113.74, 112.68, 71.24, 68.20, 55.18, 53.56, 51.06. HRMS (ESI)[M+H] + calcd for C 18 H 21 O3N2S: 345.1267, found: 345.1254. Target Compound A 19 White solid, yield 54.96%, m. p. 78.6-79.3 °C; 1 H NMR (500 MHz, CDCl3)δ 7.91 – 7.86 (m, 1H, CO-C= CH ), 7.75 (dd, J = 8.2, 0.9 Hz, 1H, S-C= CH ), 7.53 –7.47 (m, 1H, S-C=CH- CH ), 7.38 – 7.32 (m, 1H, S-C=CH-CH- CH ), 7.24 (dd, J = 15.4,7.7 Hz, 1H, H3CO-Ar-5H), 6.92 (d, J = 8.4 Hz, 2H, H3CO-Ar-2,6H), 6.80 (dd, J =8.3, 2.6 Hz, 1H, H3CO-Ar-4H), 4.59 – 4.49 (m, 2H, NH- CH2 -Ar), 4.26 (td, J = 8.9,4.9 Hz, 1H, HO- CH ), 3.92 – 3.83 (m, 2H, N- CH2 ), 3.78 (s, 3H,OCH3), 2.97 – 2.81(m, 2H, NH-CH2 ). 13 C NMR (126 MHz, CDCl3) δ 162.88, 159.89, 151.70, 139.59,129.74, 128.90, 125.08, 124.59, 123.23, 120.86, 120.23, 114.04, 113.23,71.11, 67.91, 55.33, 53.30, 50.76. HRMS (ESI) [M+H] + calcd for C 18 H 21 O3N2S:345.1267, found: 345.1253. Target Compound A 20 White solid, yield 60.97%, m. p. 119.7-120.5 °C; 1 H NMR (400 MHz,CDCl3) δ 7.90 (d, J = 8.1 Hz, 1H, CO-C= CH ), 7.76 (d, J = 8.2 Hz, 1H, S-C= CH ),7.51 (t, J = 7.6 Hz, 1H, S-C=CH- CH ), 7.37 (t, J = 7.5 Hz, S-C=CH-CH- CH ), 7.27 –7.21 (m, 2H, H3CO-Ar-2,6H), 6.85 (d, J = 8.7 Hz, 2H, H3CO-Ar-3,5H), 4.56 (qd, J =11.2, 5.0 Hz, 2H, N- CH2 ), 4.22 – 4.13 (m, 1H, N- CH2 ), 3.77 (d, J = 7.8 Hz, 5H,NH- CH2 -Ar,OCH3), 2.88 (dd, J = 12.1, 3.9 Hz, 1H, NH- CH2 ), 2.79 (dd, J= 12.2, 8.0Hz, 1H, NH- CH2 ). 13 C NMR (101 MHz, CDCl3) δ 162.93, 158.79, 151.66, 131.73,129.45, 128.82, 125.08, 124.50, 123.17, 120.19, 113.89, 71.31, 68.33, 55.30,53.13, 50.93. HRMS (ESI) [M+H] + calcd for C 18 H 21 O3N2S: 345.1267, found:345.1255. Target compound A 21 White solid, yield 24.44%, m. p. 141.1-141.4 °C; 1 H NMR (600 MHz,CDCl3) δ 7.92 (d, J = 8.3 Hz, 1H, CO-C= CH ), 7.78 (dd, J = 14.5, 8.3 Hz, 1H, S-C= CH ), 7.55 (q, J = 9.3 Hz, 1H, F3C-Ar-3H), 7.41 (dd, J = 8.3, 4.1 Hz, 3H, F3C-Ar-5H, S-C=CH-CH, S-C=CH-CH- CH ), 6.68 (d, J = 9.0 Hz, 2H, F3C-Ar-2H, F3C-Ar-6H),5.30 (s, 1H, HO- CH ), 4.69 (qd, J = 11.7, 4.8 Hz, 2H, N- CH2 ), 4.35 (s, 1H, NH- CH2 ), 3.33 (dd, J = 13.1, 7.6 Hz, 1H, NH- CH2 ). 13C NMR (151 MHz, CDCl3) δ 162.96, 151.82, 150.62, 129.21, 126.75, 124.84, 123.11, 120.43, 112.34, 71.53, 69.07, 50.99, 46.05. 19 F NMR (565 MHz, CDCl3) δ -60.82. HRMS (ESI) [M+H]+ calcd for C 17 H 16 O2N2F3S: 369.0879, found: 369.0866. Target compound A 22 White solid, yield 41.89%, m. p. 118.6-119.9 °C; 1 H NMR (600 MHz, CDCl3) δ 7.91 (d, J = 7.6 Hz, 1H, CO-C= CH ), 7.79 (d, J = 8.3 Hz, 1H, S-C= CH ), 7.57 – 7.53 (m, 1H, S-C=CH- CH ), 7.41 (t, J = 7.2 Hz, 1H, S-C=CH-CH- CH ), 7.26 – 7.24 (m, 2H, Br-Ar-3,5H), 6.56 (d, J = 8.3 Hz, 2H, Br-Ar-2,6H), 4.70 (dd, J =11.7, 3.4 Hz, 1H, HO- CH ), 4.65 (dd, J = 11.7, 6.2 Hz, 1H, N- CH2 ), 4.33 (tt, J =7.4, 4.0 Hz, 1H, N- CH2 ), 3.39 (dd, J = 13.1, 4.1 Hz, 1H, NH- CH2 ), 3.26 (dd, J =12.7, 7.2 Hz, 1H, NH- CH2). 13 C NMR (151 MHz, CDCl3) δ 162.97, 151.83, 147.10, 132.09, 129.16, 124.88, 124.81, 123.13, 120.42, 114.95, 109.69, 71.63, 69.13, 46.66. HRMS (ESI) [M+H] + calcd for C 16 H 16 O2N2BrS: 379.0110, found: 379.0099. Target Compound A 23 Yellow oil, yield 61.18%, 1 H NMR (600 MHz, CDCl3) δ 7.85 (dd, J = 8.0, 1.0 Hz, 1H, CO-C= CH ), 7.75 (dd, J = 8.2, 0.9 Hz, 1H, S-C= CH ), 7.58 (d, J = 7.8 Hz, 2H, F3C-Ar-3,5H), 7.53 – 7.49 (m, 1H, S-C=CH- CH ), 7.43 (d, J = 8.2 Hz, 2H, F3C-Ar-2,6H), 7.38 – 7.33 (m, 1H, S-C=CH-CH- CH ), 4.65 (dd, J = 11.2, 3.4 Hz, 1H, HO- CH ), 4.52 (dd, J = 11.1, 5.7 Hz, 1H, N- CH2 ), 4.29 – 4.20 (m, 1H, N- CH2 ), 3.75 (d, J = 13.4 Hz, 1H, NH- CH2 -Ar), 3.59 (d, J = 13.4 Hz, 1H, NH- CH2 -Ar), 2.69 (dd, J= 12.4, 9.7 Hz, 1H, NH- CH2 ), 2.54 (dd, J = 12.3, 4.3 Hz, 1H, NH- CH2 ), 2.31(s, 3H,CH3). 13 C NMR (126 MHz, CDCl3) δ 162.96, 151.65, 142.60, 129.68, 129.29,128.88, 125.39, 125.14, 124.54, 123.18, 120.21, 70.92, 66.43, 62.16, 59.27,50.63, 42.38. 19 F NMR (471 MHz, CDCl3) δ -62.02. HRMS (ESI) [M+H] + calcd forC 19 H 20 O2N2F3S: 397.1192, found: 397.1184. Target Compound A 24 Yellow oil, yield 42.80%, 1 H NMR (400 MHz, CDCl3) δ 7.84 (d, J = 8.1 Hz,1H, CO-C= CH ), 7.74 (d, J = 9.0 Hz, 1H, S-C= CH ), 7.50 (t, J = 7.6 Hz, 1H, S-C=CH- CH ), 7.43 (d, J = 8.3 Hz, 2H, Br-Ar-3,5H), 7.37 (t, J = 7.5 Hz, 1H, S-C=CH-CH- CH ), 7.17 (d, J = 8.3 Hz, 2H, Br-Ar-3,5H), 4.63 (dd, J = 11.1, 3.4 Hz, 1H,HO- CH ),4.49 (dd, J = 11.1, 5.6 Hz, 1H, N- CH2), 4.21 (td, J = 9.6, 3.9 Hz, 1H, N- CH2 ),3.63 (d, J = 13.2 Hz, 1H, NH- CH2 -Ar), 3.47 (d, J = 13.2 Hz, 1H, NH- CH2 -Ar), 2.66(dd, J = 12.4, 9.6 Hz, 1H, NH- CH2 ), 2.50 (dd, J = 12.3, 4.3 Hz, 1H, NH- CH2 ), 2.28(s, 3H,CH3). 13 C NMR (151 MHz, CDCl3) δ 163.19, 151.92, 137.60, 131.85, 131.04,129.09, 125.41, 124.81, 123.49, 121.48, 120.46, 71.10, 66.43, 62.22, 59.21,42.52. HRMS (ESI) [M+H] + calcd for C 18 H 20 O2N2BrS: 407.0423, found: 407.0414. Target compound A 25 White solid, yield 92.35%, m. p. 86.8-87.1 °C; 1 H NMR (500 MHz, CDCl3)δ 7.87 (dt, J = 8.1, 1.0 Hz, 1H, CO-C= CH ), 7.79 (dt, J = 8.2, 0.9 Hz, 1H, S-C= CH ), 7.54 (ddd, J = 8.3, 7.1, 1.2 Hz, 3H, S-C=CH- CH , F3C-Ar-3,5H), 7.44 – 7.38(m, 3H, S-C=CH-CH- CH, F3C-Ar-3,5H), 4.66 – 4.57 (m, 2H, N- CH2 ), 4.25 – 4.18(m, 1H, HO- CH ), 3.83 (s, 2H, SH- CH2 -Ar), 2.72 (dd, J = 13.9, 5.0 Hz, 1H, SH - CH2 ), 2.66 – 2.60 (m, 1H, SH- CH2 ). 13 C NMR (126 MHz, CDCl3) δ 162.78, 151.80,142.16, 129.38, 129.06, 125.68, 125.64, 125.62, 125.58, 124.95, 124.72,123.10, 120.36, 71.61, 69.04, 36.04, 34.65. 19 F NMR (471 MHz, CDCl3) δ -62.28.HRMS (ESI) [M+H] + calcd for C 18 H 17 O2NF3S2: 400.0647, found: 400.0635. Target Compound A 26 White oil, yield 67.93%; 1 H NMR (600 MHz, CDCl3) δ 7.85 (dd, J = 8.1, 1.0Hz, 1H, CO-C= CH ), 7.76 (dd, J = 8.1, 0.9 Hz, 1H, S-C= CH ), 7.52 (ddd, J = 8.2,7.0, 1.2 Hz, 1H, S-C=CH- CH ), 7.42 – 7.31 (m, 3H, S-C=CH-CH- CH , Br-Ar-3,5H),7.20 – 7.12 (m, 2H, Br-Ar-2,6H), 4.63 – 4.54 (m, 2H, N- CH2), 4.17 (s, 1H, HO- CH ), 3.71 (s, 2H, SH- CH2 -Ar), 3.25 (s, 1H,OH), 2.73 – 2.58 (m, 2H, SH- CH2 ). 13 13C NMR (151 MHz, CDCl3) δ 162.75, 151.73, 136.96, 131.73, 130.72, 128.99,124.94, 124.68, 123.10, 121.11, 120.31, 71.53, 68.87, 35.84, 34.61. HRMS(ESI) [M+H] + calcd for C 17 H 17 O2NBrS2: 409.9879, found: 409.9842. Target compound A 27 White solid, yield 45.89%, m. p. 62.5-64.2 ℃; 1 1H NMR (500 MHz, CDCl3)δ 7.89 (dt, J = 8.1, 1.0 Hz, 1H, CO-C= CH ), 7.77 (dt, J = 8.2, 0.9 Hz, 1H, S-C= CH ), 7.53 (ddd, J = 8.2, 7.0, 1.1 Hz, 1H, F3C-Ar-3H), 7.50 – 7.43 (m, 4H, S-C=CH-CH- CH , S-C=CH- CH , F3C-Ar-5,6H), 7.41 – 7.37 (m, 1H, F3C-Ar-2H), 4.74 – 4.64(m, 2H, N- CH2 ), 4.31 – 4.24 (m, 1H, HO- CH ), 3.54 (d, J = 4.7 Hz, 1H,OH), 3.34 –3.20 (m, 2H, SH- CH2 ). 13C NMR (101 MHz, CDCl3) δ 162.71, 151.78, 140.95, 129.04, 128.21, 127.91, 125.90, 125.86, 125.82, 125.78, 125.39, 124.78, 124.69, 123.01, 122.69, 120.33, 71.35, 69.00, 36.34. 19 F NMR (471 MHz, CDCl3) δ-62.31. HRMS (ESI) [M+H] + calcd for C 17 H 15 O2NF3S2: 386.0491, found: 386.0480. Target Compound A 28 White solid, yield 59.09%, m. p. 76.9-77.4 °C; 1 H NMR (500 MHz, CDCl3)δ 7.87 (d, J = 8.0 Hz, 1H, CO-C= CH ), 7.76 (d, J = 8.3 Hz, 1H, S-C= CH ), 7.54 –7.50 (m, 1H, S-C=CH- CH ), 7.40 – 7.32 (m, 3H, S-C=CH-CH- CH , Br-Ar-3,5H), 7.27– 7.23 (m, 2H, Br-Ar-2,6H), 4.71 – 4.60 (m, 2H, N- CH2 ), 4.19 (p, J = 5.2 Hz,1H, HO- CH ), 3.52 (d, J = 4.6 Hz, 1H,OH), 3.25 – 3.10 (m, 2H, SH-CH2 ). 13C NMR (126MHz, CDCl3) δ 162.77, 151.76, 134.60, 132.20, 131.42, 129.05, 124.90, 124.71,123.12, 120.60, 120.38, 71.29, 68.91, 37.74. HRMS (ESI) [M+H] + calcd forC 16 H 15 O2NBrS2: 395.9722, found: 395.9717. Target compound A 29 Yellow oil, yield 65.31%; 1 H NMR (400 MHz, CDCl3)δ 7.93 (d, J = 8.1 Hz, 1H, CO-C= CH ), 7.75 (d, J = 8.2 Hz, 1H, SC= CH ), 7.54 – 7.47 (m, 1H, SC=CH- CH ),7.40 – 7.32 (m, 1H, SC=CH-CH- CH ), 4.64 – 4.45 (m, 2H, N- CH2 ), 4.20 (ddt, J =9.7, 6.0, 4.0 Hz, 1H, HO- CH ), 2.82 – 2.32 (m, 10H, piperazine-8H, piperazine- CH2 ), 2.28 (s, 3H,CH3). 13 C NMR (101 MHz, CDCl3) δ 162.89, 151.64, 128.75,125.14, 124.44, 123.20, 120.16, 71.05, 65.42, 60.09, 55.14, 46.02. HRMS (ESI)[M+H] + calcd for C 15 H 22 O2N3S:308.14, found: 308.14. Target compound A 30 Yellow oil, yield 70.71%; 1 H NMR (500 MHz, CDCl3) δ 7.95 (d, J = 7.9 Hz,1H, CO-C= CH ), 7.76 (d, J = 7.9 Hz, 1H, S-C= CH ), 7.54 – 7.48 (m, 1H, S-C=CH- CH ),7.38 (t, J = 7.6 Hz, 1H,1-H, S-C=CH-CH- CH ), 4.61 (dd, J = 11.0, 3.4 Hz, 1H, HO- CH ), 4.51 (dd, J = 11.2, 6.0 Hz, 1H, N- CH2 ), 4.21 (ddt, J = 10.0, 6.2, 4.0 Hz,1H, N- CH2 ), 2.84 – 2.37 (m, 12H, piperazine-8H , piperazine- CH2 ,CH3 CH2 ), 1.09(t, J = 7.2 Hz, 3H,CH3). 13 C NMR (101 MHz, CDCl3) δ 162.86, 151.58, 128.78,125.08, 124.47, 123.17, 120.14, 71.03, 65.59, 60.24, 52.62, 52.24, 50.34,11.62. HRMS (ESI) [M+H] + calcd for C 16 H 24 O2N3S: 322.1584, found: 322.1572. Target compound A 31 Yellow oil, yield 74.96%; 1H NMR (600 MHz, CDCl3) δ 7.92 (d, J = 8.3 Hz,1H, CO-C= CH ), 7.73 (d, J = 7.6 Hz, 1H, S-C= CH ), 7.48 (t, J = 7.2 Hz, 1H, S-C=CH- CH ), 7.34 (t, J = 7.6 Hz, 1H, S-C=CH-CH- CH ), 4.59 (dd, J = 11.0, 4.1 Hz, 1H, HO- CH ), 4.49 (dd, J = 10.7, 5.9 Hz, 1H, N- CH2 ), 4.23 – 4.15 (m, 1H, N- CH2 ), 2.66 –2.40 (m, 10H, piperazine-8H, piperazine- CH2 ), 1.03 (d, J = 6.2 Hz, 7H,piperazine- CH(CH3)2 ). 13 C NMR (101 MHz, CDCl3) δ 162.84, 151.52, 128.74, 125.05,124.42, 123.13, 120.10, 71.07, 65.59, 60.35, 54.62, 50.03, 48.57, 18.42. HRMS(ESI) [M+H] + calcd for C 17 H 26 O2N3S: 336.1740, found: 336.1728. Target compound A 32 Yellow oil, yield 85.19%; 1 H NMR (400 MHz, CDCl3) δ 7.94 (dt, J = 8.1,1.0 Hz, 1H, CO-C= CH ), 7.75 (d, J = 8.2 Hz, 1H, S-C=CH ), 7.50 (ddd, J = 8.2,7.0, 1.2 Hz, 1H, S-C=CH- CH ), 7.39 – 7.34 (m, 1H, S-C=CH-CH- CH ), 4.61 (dd, J =11.1, 3.7 Hz, 1H, HO- CH ), 4.50 (dd, J = 11.1, 5.9 Hz, 1H, N- CH2 ), 4.24 – 4.17(m, 1H, N- CH2 ), 2.80 – 2.31 (m, 12H, piperazine-8H, piperazine- CH2 ,piperazine- CH2- CH2), 1.53 – 1.43 (m, 2H, piperazine-CH2- CH2 -CH2), 1.31 (dq, J =14.2, 7.2 Hz, 2H, piperazine-CH2-CH2- CH2 -CH3), 0.91 (t, J = 7.3 Hz, 3H,CH3). 13 C NMR (101 MHz, CDCl3) δ 162.90, 151.65, 128.75, 125.14, 124.43, 123.21,120.16, 71.06, 65.43, 60.10, 58.43, 53.24, 28.89, 20.77, 14.08. HRMS (ESI) [M+H] + calcd for C 18 H 28 O2N3S: 350.1897, found: 350.1884. Target compound A 33 White solid, yield 25.37%, m. p. 96.8-97.5 ℃; 1 H NMR (600 MHz, CDCl3)δ 7.94 (d, J = 8.3 Hz, 1H, CO-C=CH ), 7.75 (d, J = 8.3 Hz, 1H, S-C= CH ), 7.49 (t, J= 7.6 Hz, 1H, S-C=CH- CH ), 7.36 (t, J = 7.6 Hz, 1H, S-C=CH-CH- CH ), 6.84 (s,1H, piperazine-CH2-Ar-2H), 6.73 (s, 2H, piperazine-CH2-Ar-5,6H), 4.64 – 4.46(m, 2H,O- CH2 -O), 4.19 (td, J = 6.5, 3.1 Hz, 1H, HO- CH ), 3.41 (s, 2H, N- CH2 ),3.09 – 1.92 (m, 12H, piperazine-8H, piperazine- CH2 , piperazine- CH2 -Ar). 13 C NMR(151 MHz, CDCl3) δ 162.99, 151.72, 147.70, 146.69, 131.99, 128.80, 125.23,124.50, 123.29, 122.33, 120.23, 109.68, 107.96, 100.99, 71.16, 65.48, 62.78,60.20, 53.05.HRMS (ESI) [M+H] + calcd for C 22 H 26 O4N3S: 428.1639, found: 428.1629. Target compound A 34 Yellow oil, yield 60.65%, 1 H NMR (500 MHz, CDCl3) δ 7.92 (dd, J = 7.9,3.4 Hz, 1H, CO-C= CH ), 7.72 (d, J = 8.3 Hz, 1H, S-C= CH ), 7.47 (t,J = 8.3 Hz, 1H, S-C=CH- CH ), 7.34 (t, J = 7.6 Hz, 1H, S-C=CH-CH- CH ), 4.60 – 4.43 (m, 2H, N- CH2 ),4.20 – 4.06 (m, 1H, HO- CH ), 3.03 – 2.85 (m, 1H, piperidine- CH2 ), 2.81 – 2.67(m, 1H, piperidine- CH2 ), 2.66 – 2.32 (m, 2H, piperidine-6H), 2.29 – 2.06 (m,1H, piperidine-2H), 1.70 – 1.43 (m, 4H, piperidine-4,5H), 1.40 – 1.21 (m, 2H,piperidine-3H), 1.06 (dd, J = 11.0, 6.2 Hz, 3H,CH3). 13 C NMR (101 MHz, CDCl3) δ162.93, 151.67, 128.75, 125.19, 124.45, 123.21, 120.14, 71.21, 71.07, 66.18,64.79, 56.80, 56.39, 55.00, 52.54, 34.35, 32.76, 25.75, 25.33. HRMS (ESI) [M+H] + calcd for C 16 H 23 O2N2S: 307.1475, found: 307.1462. Target compound A 35 Yellow oil, yield 52.3%, 1 H NMR (600 MHz, CDCl3) δ 7.96 (d, J = 7.8 Hz,1H, CO-C= CH ), 7.76 (d, J = 8.2 Hz, 1H, S-C= CH ), 7.51 (t,J = 7.1 Hz, 1H, S-C=CH- CH ), 7.37 (t, J = 7.5 Hz, 1H, S-C=CH-CH- CH ), 4.65 – 4.42 (m, 2H, N- CH2 ), 4.21(dddd, J = 13.8, 9.9, 6.3, 3.9 Hz, 1H, HO- CH ), 3.05 – 2.72 (m, 2H, piperidine- CH2 ), 2.59 – 2.41 (m, 2H, piperidine-6H), 1.94 (q, J = 10.6 Hz, 1H, piperidine-2H), 1.76 – 1.62 (m, 4H, piperidine-4,5H), 1.25 (s, 1H, piperidine-2H), 0.88 (d, J = 18.2 Hz, 4H, piperidine-3H, CH3). 13 C NMR (151 MHz, CDCl3) δ 163.04, 151.71, 128.79, 125.28, 124.48, 123.33, 120.21, 71.23, 65.27, 60.62, 60.49, 55.65, 52.84, 32.85, 32.79, 31.45, 31.24, 25.75, 25.49, 19.68, 19.61. HRMS (ESI) [M+H] + calcd for C 16 H 23 O2N2S: 307.1475, found: 307.1464. Target Compound A 36 Yellow oil, yield 81.16%, 1 H NMR (400 MHz, CDCl3) δ 7.95 (dt, J = 8.0, 1.0 Hz, 1H, CO-C= CH ), 7.78 – 7.73 (m, 1H, S-C= CH ), 7.50 (ddd,J = 8.2, 7.0, 1.2Hz, 1H, S-C=CH- CH ), 7.36 (ddd, J = 7.9, 7.0, 0.9 Hz, 1H, S-C=CH-CH- CH ), 4.59(dd, J = 11.0, 3.6 Hz, 1H, HO- CH ), 4.49 (dd, J = 11.1, 6.0 Hz, 1H, N- CH2 ), 4.19(ddt, J = 9.9, 6.0, 3.9 Hz, 1H, N- CH2 ), 3.02 – 2.96 (m, 1H, piperidine- CH2 ),2.81 (ddt, J = 12.9, 5.0, 2.3 Hz, 1H, piperidine- CH2 ), 2.56 – 2.44 (m, 2H,piperidine-2H), 2.29 (td, J = 11.5, 2.5 Hz, 1H, piperidine- CH2 ), 1.98 (td, J =11.6, 2.5 Hz, 1H, piperidine-6H), 1.63 (dt, J = 12.6, 2.5 Hz, 2H, piperidine-4,6H), 1.45 – 1.10 (m, 4H, piperidine-3,5H), 0.92 (d, J = 6.4 Hz, 3H,CH3). 13 CNMR (101 MHz, CDCl3) δ 163.03, 151.70, 128.77, 125.27, 124.46, 123.32,120.19, 71.27, 65.39, 60.45, 52.66, 34.65, 34.32, 30.74, 21.95. HRMS (ESI) [M+H] + calcd for C 16 H 23 O2N2S: 307.1475, found: 307.1463. Target Compound A 37 White soild, yield 65.36%, m. p. 83.4-85.1 ℃; 1 H NMR (400 MHz, CDCl3)δ 7.92 (d, J = 8.1 Hz, 1H, CO-C= CH ), 7.77 (d, J = 8.2 Hz, 1H, S-C= CH ), 7.52 (t, J =7.6 Hz, 1H, S-C=CH- CH ), 7.41 – 7.33 (m, 2H, S-C=CH-CH- CH , furan-3H), 6.31(dd, J = 3.2, 2.0 Hz, 1H, furan-4H), 6.22 (d, J = 3.3 Hz, 1H, furan-5H), 4.61(dd, J = 11.2, 3.9 Hz, 1H, HO- CH ), 4.54 (dd, J = 11.2, 6.0 Hz, 1H, furan- CH2 ),4.23 – 4.13 (m, 1H, furan- CH2 ), 3.86 (s, 2H, N- ​ ), 2.90 (dd, J = 12.3, 4.0 Hz,1H, NH- ​ ), 2.80 (dd, J = 12.2, 8.2 Hz, 1H, NH- ​ ). 13 C NMR (151 MHz, CDCl3) δ162.94, 152.61, 151.74, 142.30, 128.89, 125.11, 124.58, 123.24, 120.25,110.36, 107.91, 71.23, 68.23, 50.70, 45.77. HRMS (ESI) [M+H] + calcd forC 15 H 17O3N2S: 305.0954, found: 305.0940. Target compound A 38 White solid, yield 76.71%, m.p. 100.4-101.3 °C; 1 ¹H NMR (400 MHz, CDCl₃) δ 7.91 (d, J = 8.1 Hz, 1H, CO-C= ​ ), 7.77 (d, J = 8.2 Hz, 1H, S-C= ​ ), 7.52 (t, J =7.6 Hz, 1H, S-C=CH- ​ ), 7.38 (t, J = 7.5 Hz, 1H, S-C=CH-CH- ​ , thiophene-3H),7.25 – 7.17 (m, 1H, thiophene-5H), 6.95 (d, J = 3.7 Hz, 2H, thiophene-4H), 4.62(dd, J = 11.2, 4.0 Hz, 1H, HO- ​ ), 4.55 (dd, J = 11.2, 6.0 Hz, 1H, thiophene- ​ ), 4.22 – 4.15 (m, 1H, thiophene- ​ ), 4.06 (s, 2H, N- ​ ), 2.95 (dd, J =12.2, 4.0 Hz, 1H, NH- ​ ), 2.84 (dd, J = 12.2, 7.9 Hz, 1H, NH- ​ ). 13C NMR (151MHz, CDCl3) δ 163.24, 151.99, 143.49, 129.16, 127.08, 125.69, 125.36, 125.09,124.84, 123.48, 120.52, 71.60, 68.79, 51.05, 48.50. HRMS (ESI) [M+H] + calcdfor C 15 H 17 O2N2S2: 321.0726, found: 321.0712. Target compound A 39 Yellow oil, yield 63.84%, 1 H NMR (500 MHz, CDCl3) δ 7.92 (d, J = 8.0 Hz,1H, CO-C= ​ ), 7.73 (d, J = 8.2 Hz, 1H, S-C= ​ ), 7.47 (ddd, J = 8.2, 7.0, 1.2 Hz,1H, S-C=CH- ​ ), 7.36 – 7.31 (m, 1H, S-C=CH-CH- ​ ), 4.59 (dd, J = 11.1, 3.5 Hz,1H, N- ​ ), 4.48 (dd, J = 11.1, 6.0 Hz, 1H, N- ​ ), 4.19 (ddt, J = 9.9, 6.0, 3.7Hz, 1H, HO- ​ ), 2.86 – 2.34 (m, 10H, piperidine-8H, piperidine- ​ ), 1.05 (s,9H,C ​ ). 13C NMR (126 MHz, CDCl3) δ 162.98, 151.69, 128.77, 125.22, 124.46,123.27, 120.19, 71.20, 65.44, 60.18, 54.01, 53.86, 53.56, 45.77, 26.08. HRMS(ESI) [M+H] + calcd for C 18 H 28 O2N3S: 350.1897, found: 350.1862. Example 2 In vitro antibacterial activity assay: turbidimetric method Culture medium preparation: NB medium contains 20 g glucose, 6 g beef extract, 10 g peptone, and 2 g yeast extract, dissolved in 2 L of deionized water. Adjust the pH to 7.18-7.20 with 5 mol / L NaOH. Sterilize at 121 ℃ for 20 min. EC 50 Assay (turbidimetric method): Initial concentration assessments were set at 100 μg / mL and 50 μg / mL. Based on the preset concentration range of the target compound, a serial dilution method (two-fold stepwise dilution) was used to prepare gradient solutions for the target compound and positive control, setting final concentration gradients of 100, 50, 25, 12.5, 6.25, and 3.12 μg / mL. 1 mL of each concentration solution was mixed with 4 mL of sterile NB, and 40 μL of Xoo bacterial suspension (OD200) was added. 595 ≈0.6 (logarithmic phase), incubated at 28 ℃ with shaking at 180 rpm for 24–48 h. Absorbance at 595 nm (OD) was measured using Cytation™ 5. 595 Using DMSO-containing culture medium as a negative control and a commercially available fungicide as a positive control, a linear regression (y = ax + b) was performed on the log concentration using probit analysis to derive the virulence equation and EC50. 50 .

[0016] Table 1. Compounds A1-A 39 right ​ , ​ and ​ Preliminary screening results of in vitro antibacterial activity a

[0017] a: Average of three repeated trials; BT: Dimethicone; TC: Thiadiazole copper.

[0018] Table 2. Compounds A1-A 39 right ​ half-maximal effective concentration (EC50) 50 ) Measurement a

[0019] a: Average of three repeated trials; BT: Dimethicone; TC: Thiadiazole copper.

[0020] Table 3. Compounds A1-A 39 right ​ half-maximal effective concentration (EC50) 50 ) Measurement a

[0021] a: Average of three repeated trials; BT: Dimethicone; TC: Thiadiazole copper.

[0022] Biological tests showed that the synthesized compound, at a concentration of 100 μg / mL, was effective against pathogens. ​ and ​ All showed good inhibitory activity, with some compounds even approaching or achieving complete inhibition (see Table 1). Further screening results showed that these compounds exhibited good inhibitory activity against... ​ EC 50 The values ​​ranged from 3.36 μg / mL to 39.71 μg / mL (see Table 2), showing significant superiority over the commercial fungicide bismuth subtilis (BT, EC). 50 = 44.0 μg / mL) and thiamethoxam (TC, EC) 50 = 84.26 μg / mL). EC50 for Xac 50 The values ​​ranged from 4.87 μg / mL to 40.92 μg / mL (see Table 3), which was significantly better than the commercial fungicide bismuth subtilis (BT, EC). 50 = 52.59 μg / mL) and thiamethoxam (TC, EC) 50 = 72.53 μg / mL).

[0023] The following conclusions were drawn from the structure-activity relationship (SAR): 1) Targeting the pathogen of rice bacterial blight ​ The antibacterial activity test results showed that when the substituent on benzylamine was an electron-withdrawing group, the compound generally exhibited better antibacterial activity, with its EC50 values ​​being [missing information]. 50 The values ​​are as follows: A 12 (EC 50 = 3.36 μg / mL)>A3(EC 50 = 4.18 μg / mL)>A8(EC 50 = 4.48 μg / mL)>A9(EC50 =6.04 μg / mL)>A5(EC 50 = 10.54 μg / mL); When the substituent on benzylamine is an electron-donating group, the compound's activity is relatively good, but lower than that of compounds substituted with electron-withdrawing groups. Their EC50 values ​​are as follows: A 20 (EC 50 = 10.30 μg / mL)>A 15 (EC 50 = 12.83 μg / mL)>A 18 (EC 50 = 13.77 μg / mL)>A 19 (EC 50 = 15.47 μg / mL)>A 17 (EC 50 = 20.48μg / mL)>A 10 (EC 50 = 23.50 μg / mL); 2) In the case of ​ In the evaluation of antibacterial activity, when the substituent R is a benzylamine group, and when the substituent on the benzylamine is an electron-withdrawing group, the compound generally exhibits better antibacterial activity and its EC50 values ​​are higher. 50 The values ​​are as follows: A 12 (EC 50 =4.87 μg / mL)>A3(EC 50 = 6.34 μg / mL)>A9(EC 50 = 6.52 μg / mL)>A2(EC 50 = 6.93 μg / mL)>A 10 (EC 50 = 8.07 μg / mL)>A5(EC 50 = 10.63 μg / mL); When the substituent on benzylamine is an electron-donating group, the compound's activity is relatively good, but relatively lower than that of compounds substituted with electron-withdrawing groups, and its EC50 is 10.63 μg / mL. 50 The values ​​are as follows: A 15 (EC 50 = 7.32 μg / mL)>A 17 (EC 50 = 9.58 μg / mL)>A 20 (EC 50 = 11.95 μg / mL)>A 19 (EC 50 = 13.45 μg / mL)>A 18 (EC 50 = 15.12 μg / mL)>A 16 (EC 50= 16.21 μg / mL). (2) When the substituent R is a substituted aniline, N When the structures of -methylbenzylamine, benzyl thiol, and benzyl thiol are used, the corresponding compounds do not exhibit any effect on... ​ Inhibitory activity, typically represented by A 21 A 22 A 23 A 25 A 26 A 27 A 28 etc. For citrus canker pathogens. ​ The antibacterial test results also showed that the above compounds exhibited only weak inhibitory effects, and... ​ It has virtually no antibacterial effect. (3) If R is a substituted heterocyclic structure, the resulting derivative is as follows: 29 A 30 A 31 A 32 A 35 A 36 etc., for ​ It also does not possess significant antibacterial activity, and is... ​ and ​ It also did not show any inhibitory effect.

[0024] Example 3 1. Toxicity test This invention relates to preferred compound A 12 This invention utilizes the ADMETlab 2.0 platform to conduct systematic evaluations of the toxicity and safety of human cells, environmental organisms, and crops. 12 Physicochemical, absorption and non-target toxicity prediction in humans, A 12 The compound exhibited good safety profile in humans regarding passive diffusion and intestinal absorption of Caco-2 and MDCK, with a skin sensitization probability of 0.044, an eye corrosion probability of 0.004, and an eye irritation probability of 0.012. Based on the predicted results, this compound did not show intermediate to high levels of toxicity, demonstrating excellent safety potential for human use. A 14-day acute toxicity test on non-target earthworms in soil confirmed that at an exposure concentration of 10 mg / kg, the earthworm survival rate was 100%. 12 For earthworms LC 50 Greater than 10 mg / kg, classifying it as a low-toxicity, environmentally friendly compound. Six cell lines were selected for in vitro toxicology testing: HEK-293 (kidney), HL-7702 (liver), MRC-5 (lung), CACO-2 (intestinal barrier), HepG2 (liver metabolism), and RAW264.7 (immune / macrophage). 12 Cellular IC 50Compared to the positive control 5-fluorouracil, it exhibits lower cytotoxicity. Plant toxicity tests on greenhouse rice showed that treatment with two field application concentrations of 200 μg / mL and 500 μg / mL for 7 days resulted in no yellowing or wilting symptoms, indicating safety for the rice crop. Based on comprehensive multiple toxicity tests, compound A of this invention... 12 It has a low risk of pesticide damage and good safety.

[0025] 2. Antibacterial mechanism With compound A 12 As the research subject, rice bacterial blight fungus ( ​ Using a model, this study systematically explored the antibacterial mechanism, focusing on changes in bacterial growth, biofilm formation, motility, extracellular pathogenic enzymes, and plant pathogenicity. The pathway of action was clarified through bacterial growth curve determination, quantitative detection of biofilm, swimming and swarming experiments, extracellular amylase / cellulase activity analysis, in vivo pathogenicity assays in rice, and hypersensitivity tests in tobacco.

[0026] Bacterial growth curve analysis results showed that 0~2 EC 50 Concentration range A 12 Only for ​ Produces a slight subinhibitory effect, 4EC 50 Concentration can significantly inhibit ​ Bacterial cell proliferation indicates a high concentration of A 12 It can directly inhibit bacterial reproduction. Quantitative biofilm assays show that 1 / 2 EC 50 ~EC 50 A at concentration 12 No impact ​ Normal growth is observed, but biofilm formation is significantly inhibited, disrupting the protective barrier of bacteria against external stresses. Swimming and gregarious movement experiments confirm that A... 12 Inhibition in the form of concentration gradient ​ Athletic ability, 4EC 50 Under certain conditions, the swimming inhibition rate was 86.74%, and the clustering inhibition rate was 96.60%, significantly weakening the pathogen's ability to migrate and colonize within the plant. Extracellular enzyme activity assays showed that A... 12 Concentration dependence decreases ​ Amylase and cellulose secretion levels, 4 EC 50 At 2EC, the amylase inhibition rate was 94.65% and the cellulase inhibition rate was 87.71%, blocking the infection pathway of pathogen degradation of rice cell walls. Rice pathogenicity testing showed that 2EC... 50 4EC 50 The lesion inhibition rates in the treatment groups were 39.23% and 66.06%, respectively. Microscopic observation revealed that the lesion inhibition rate increased with the development of A. 12 As the concentration increased, the bacterial density within rice tissues continued to decrease. Tobacco hypersensitivity tests showed that A...12 The higher the concentration, ​ The smaller the area of ​​induced leaf necrosis, the significantly lower the pathogenicity of the pathogen.

[0027] In conclusion, we can deduce that A 12 Mainly by inhibiting ​ The pathogen weakens its virulence and reduces its ability to infect rice through multiple pathways, including biofilm formation, blocking bacterial movement and aggregation, downregulating the secretion of extracellular pathogenic enzymes, and directly inhibiting bacterial proliferation at high concentrations, thus achieving efficient control of rice bacterial blight.

Claims

1. A novel class of 1,2-benzisothiazol-3(2H)-one derivatives containing an isopropanolamine structure, characterized by: H The structural formula is shown as (1): ​ (1) Wherein R is one of aniline derivatives, thiophenol derivatives, piperidine derivatives, 2-thiophenemethylamine, 2-furanylmethylamine or piperazine derivatives.

2. A novel class of 1,2-benzisothiazol-3(2H)-one derivatives containing an isopropanolamine structure, characterized by: H The following compounds are included: ​ 3. A novel 1,2-benzisothiazole-3(2) containing an isopropanolamine structure according to claim 1 or 2. H A method for preparing ketone derivatives, characterized in that: The synthetic reaction equation is as follows:

4. Use of a novel class of 1,2-benzisothiazol-3(2H)-one derivatives of the structure of isopropylamine according to claim 1 or 2, characterized by: H The application of the derivatives in bactericides. ​ 5. Use of a novel class of 1,2-benzisothiazol-3(2H)-one derivatives containing an isopropanolamine structure according to claim 4, characterized by: H The bactericide is for killing xanthomonas oryzae and xanthomonas citri. ​